Han Yang

Shenyang Pharmaceutical University — China

Biochemistry, Genetics and Molecular Biology · Life Sciences

19h-index1.4kcitations64works2.62yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

RNA modifications and cancer(12), MicroRNA in disease regulation(7), Epigenetics and DNA Methylation(6), Cancer-related gene regulation(5), Cancer-related molecular mechanisms research(4)

Publications64 total

Cellular insights into hydrocephalus: The diverse roles and intricate crosstalk of multiple cell types
Experimental Neurology·2025Open Access
CES3 promotes NSCLC progression via lipid metabolic reprogramming regulated by TFAP2A
Journal of Cancer·2025Open Access
Programmed cell death-related genes define distinct molecular subtypes and risk profiles in hepatocellular carcinoma
Scientific Reports·2025· 1 citedOpen Access
Functional characterization of Alzheimer’s disease genetic variants in microglia
UNC Libraries·2025Open Access
High-throughput PRIME-editing screens identify functional DNA variants in the human genome
UNC Libraries·2025Open Access
Engineered nanoplatform potentiates atherosclerosis treatment by simultaneously inhibiting activated neutrophil trafficking and NETosis
Chemical Engineering Journal·2025
Screening and Validation of Negative Regulators of the Type I Interferon Pathway
Advanced Biology·2025
<scp>ABIDA</scp>: An Automated Brain Imaging Data Processing and Analysis Platform
CNS Neuroscience & Therapeutics·2025Open Access
A comprehensive multi-omics analysis uncovers the associations between gut microbiota and pancreatic cancer
Frontiers in Microbiology·2025· 5 citedOpen Access
Comparative characterization of human accelerated regions in neurons
Nature·2025· 15 cited
The acute effect of bitemporal electroconvulsive therapy on synchronous changes in heart rate variability and heart rate in patients with depression
Physiological Measurement·2025· 1 cited
Nanoassemblies of the redox paclitaxel prodrug with the natural active ingredient dihydroartemisinin for therapy of breast cancer
Nanoscale·2025· 1 cited
Assembly of a reference-quality genome and resequencing diverse accessions of Beckmannia syzigachne provide insights into population structure and gene family evolution
Plant Communications·2024· 1 citedOpen Access
FGF7 enhances the expression of ACE2 in human islet organoids aggravating SARS-CoV-2 infection
Signal Transduction and Targeted Therapy·2024· 12 citedOpen Access
High-throughput PRIME-editing screens identify functional DNA variants in the human genome
Molecular Cell·2023· 61 citedOpen Access
Design of a Multiparameter Adjustable Portable Electroconvulsive Therapy Device
2023
Functional characterization of Alzheimer’s disease genetic variants in microglia
Nature Genetics·2023· 72 citedOpen Access
Akkermansia muciniphila: A potential target and pending issues for oncotherapy
Pharmacological Research·2023· 43 citedOpen Access
Functional characterization of gene regulatory elements and neuropsychiatric disease-associated risk loci in iPSCs and iPSC-derived neurons
2023· 7 citedOpen Access
High throughput PRIME editing screens identify functional DNA variants in the human genome
2023· 17 citedOpen Access
page 1 of 4Next →

Frequent Co-authors

Yin Shen(6), Hui Yang(5), Yanting Zhou(5), Xin‐Xia Tian(5), Weigang Fang(5), Hye Seung Lee(4), Woo Ho Kim(4), Yue‐Hang Geng(4), Yanfei Huo(4), Hongquan Zhang(4), Yun Li(4), Cooper Beaman(4), Xiaoyu Yang(3), Xingjie Ren(3), Xiekui Cui(3), Shunli Fu(3), Lili Chang(3), Xiao Sang(3), Xiaoqing Liu(3), Huizhen Yang(3)